首页> Frontiers in endocrinology> Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes.

Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marta,Bassi

第一单位： DINOGMI - Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.;Pediatric Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

作者： Marta,Bassi ^[1] ; Giordano,Spacco ^[2] ; Federico,Pezzotta ^[2] ; Margherita,Di Jorgi ^[2] ; Giulia,Siri ^[3] ; Andrea,Pintabona ^[4] ; Maria Grazia,Calevo ^[5] ; Nicola,Minuto ^[6] ; Mohamad,Maghnie ^[1]

作者单位： DINOGMI - Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.;Pediatric Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy. ^[1] DINOGMI - Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy. ^[2] Department of Pediatrics and Neonatology, IRCCS Istituto Giannina Gaslini, Pietra Ligure, Italy. ^[3] Clinical Psychology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy. ^[4] Biostatistics Unit, Scientific Directorate, IRCCS Istituto Giannina Gaslini, Genoa, Italy. ^[5] Pediatric Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy. ^[6]

关键词 AHCL (advanced hybrid closed loop)AID (automated insulin delivery)CGM (continuous glucose monitoring)MiniMed 780G?TIR (time in range)active insulin time (AIT)glucose target (GT)type 1 diabetes (T1D)